How will the panel of vaccine experts handle the recent developments in vaccine situations, such as Wakefield’s article rennouncement by The Lancet, or the Swine Influenza vaccine?
Greetings, dear readers! I’m happy to present a new section of this blog, termed Meet the Speakers. Every week, we’ll introduce another of the lecturers and panelists in the up-and-coming ILSI-BioMed 2010 week. I hope it makes for an interesting reading!
The last year, as well as the current one, has seen some very interesting developments in the field of vaccines. A new vaccine entered the market against a new threat: the swine influenza. While Israel’s prime minister Benjamin Natanyau has ordered an enormous amount of these vaccines, the public votes with its’ legs and chooses to abstain from the shot. Another move forward took place when Andrew Wakefield’s paper, which heralded the age of autism-vaccine paranoia, was at long last deleted from The Lancet’s archives. A polish study lately revealed (although I’m not quite sure how much confidence can be placed in the results) that children who receive the Measles-Mumps-Rubella vaccine are actually at a lesser risk to turn out autistic, when compared to children who receive separate vaccines. An interesting year indeed. In the upcoming ILSI-BioMed week 2010 there is going to be a three-hours seminar about vaccines, which I’m definitely going to attend as an audience. While the program still doesn’t mention exactly what the speakers are going to talk about, the moderator of the panel is Dr. Ronald Ellis, who has authored and coauthored over 100 publications and 35 review articles mostly in the field of vaccines. He has also made over 100 invited presentations, and is the founding and incumbent editor-in-chief of the peer-reviewed indexed journal Human Vaccines. Other contributors to the panel will be Dr. Heather L. Davis, Dr. Sohail Ahmed, Dr. Nathalie Garson, and Dr. Jim Tartaglia. As I said, I don’t know exactly what each of them is about to say, but considering all the recent developments in the field of vaccines, I’m sure it’ll be worth hearing.
Popularity: 2% [?]
NewPR – content development, technology, and social media strategies
2 Responses to “Meet the Speakers: A Seminar about Vaccines in ILSI-BioMed 2010 Week”